Mission
Deliver regulatory-ready APIs and intermediates to speciality pharma companies who cannot afford a failed inspection.
Since 2016, Operant Scientific has been building an Indian CDMO that European and North American procurement teams choose specifically because we don't cut corners on regulatory work.
Operant Scientific Private Limited is an Indian pharmaceutical research and manufacturing company specialising in Active Pharmaceutical Ingredients (APIs), intermediates, and CDMO/CMO services. Since 2016 we have shipped into 20+ countries under WHO-GMP and MHRA-aligned frameworks, with a clean inspection record every year since our first audit.
We're a chemistry-first team. Our directors are on the plant floor, our QA leads sign every batch record, and our regulatory affairs group prepares each market's dossier in-house rather than outsourcing it. That's how we keep answers short during audits and turnarounds fast during tech transfer.
Our clients are speciality pharma companies in Europe, North America, and Asia-Pacific who need an Indian supplier that treats regulatory work as an engineering discipline, not a checklist. If that's what you're evaluating, you're reading the right page.
Deliver regulatory-ready APIs and intermediates to speciality pharma companies who cannot afford a failed inspection.
The default Indian CDMO on European and North American procurement scorecards — chosen for engineering, not price.
Build the process discipline that raises the credibility of Indian CDMOs as a whole.
Not generic mission statements. Specific behaviours we practice every day — and that clients can hold us to.
Every recommendation is grounded in lab-verified chemistry, not marketing.
Documentation is complete at each shift change, not before the inspector lands.
We report our own deviations before you find them. Speed matters more than optics.
QA signs. Not delegated. Not automated. Human-in-the-loop on every batch.
On fee-for-service work, process IP is yours. Full stop.
Operant Scientific begins as a chemistry-led practice with a small team from India's academic and pharma sector.
Regulatory submission accepted by an Asia-Pacific health authority, establishing our credibility for cross-border supply.
Distribution partners active in APAC, LATAM, and the Middle East. First tonne-scale API campaign completed on schedule.
Formal transition from partnership to Pvt. Ltd. establishes corporate governance, board structure, and long-term scale plan.
Multi-tonne API production comes online with dedicated QC lab and stability chambers meeting ICH Q1B.
Twentieth country registration cleared. Vendor onboarding portal launches for supplier-side WHO cGMP screening.
Dedicated route scouting group runs concurrent programmes for European speciality pharma, cutting PMI on multiple molecules.
Our compliance framework is anchored to WHO-GMP and aligned to MHRA expectations. Every dossier we submit is prepared by an in-house team that has sat across the table from EU and Asia-Pacific inspectors.
We publish measurable sustainability KPIs and update them annually. Below is the current baseline — the full report is available on request.
Solvent recovery, closed-loop water systems, and green-chemistry alternatives evaluated on every new route.
Local hiring, apprenticeships, and healthcare initiatives in and around Pali. We hire chemists from Rajasthan universities.
Zero-tolerance code of conduct, independent whistle-blower channel, and transparent supplier due-diligence.
Our directors and department heads run this business hands-on. Meet them, read their credentials, and see the publications behind the decisions.
Non-confidential enquiries answered within four business hours. Confidential ones under NDA within one business day.
Chat with us